These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
    Author: Pelizzo MR, Torresan F, Da Roit A, Merante Boschin I, Chondrogiannis S, Rampin L, Colletti PM, Vinjamury S, Perkins AJ, Rubello D.
    Journal: Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439.
    Abstract:
    Many open questions remain to be elucidated about the diagnosis, treatment and prognosis of medullary thyroid cancer (MTC). The most intriguing concerns the outcome of MTC patients after surgery. Great importance is usually given to serum calcitonin (Ct) and carcinoembryonic (CEA) levels. It is commonly believed that the higher are the levels of these tumor markers and their kinetics (double time and velocity of markers levels) the worst is the prognosis. However, this is not the rule, as there are huge MTC metastatic deposits characterized by low serum Ct and CEA levels, and this condition is not closely related to the outcome of the disease during post-surgical follow-up. A series is reported here of patients who have these characteristics, as well as a description of their prognosis and clinical outcome.
    [Abstract] [Full Text] [Related] [New Search]